IP Library › Granted Patent US 12,207,544
Granted Patent B2
US 12,207,544 · App. 17/356,369 · Granted Jan 21, 2025

Light-emitting device, electronic apparatus including the same, and organometallic compound

Inventors: Junghoon Han (Yongin-si, KR); Soonki Kwon (Jinju-si, KR); Yunhi Kim (Jinju-si, KR); Soobyung Ko (Yongin-si, KR); Jaesung Lee (Yongin-si, KR); Minjae Sung (Jinju-si, KR)
Assignees: Samsung Display Co., Ltd.; Industry-Academic Cooperation Foundation Gyeongsang National University
H10K85/346C07F15/0086C09K11/06C09K2211/1007C09K2211/1029C09K2211/1044C09K2211/185H10K50/11H10K2101/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,207,544
App. No.
17/356,369
Granted
Jan 21, 2025
Kind
B2
Abstract

Provided are an organometallic compound represented by Formula 1, a light-emitting device including the same, and an electronic apparatus including the light-emitting device. The light-emitting device includes: a first electrode; a second electrode facing the first electrode; and interlayer between the first electrode and the second electrode and including an emission layer, wherein the emission layer includes an organometallic compound represented by Formula 1.

Claims (144)

1. A light-emitting device comprising:

a first electrode;

a second electrode facing the first electrode;

an interlayer between the first electrode and the second electrode and comprising an emission layer,

wherein the emission layer comprises an organometallic compound represented by Formula 1:

wherein, in Formula 1, M is platinum (Pt), palladium (Pd), gold (Au), nickel (Ni), silver (Ag), or copper (Cu),

in Formula 1, X 1 to X 4 are each independently C or N,

in Formula 1, i) a bond between X 1 and M is a coordinate bond, and ii) one bond selected from a bond between X 2 and M, a bond between X 3 and M, and a bond between X 4 and M is a coordinate bond, and the remaining two bonds are covalent bonds,

in Formula 1, ring CY 1 is i) an X 1 -containing 5-membered ring, ii) an X 1 -containing 5-membered ring condensed with at least one 6-membered ring, or iii) an X 1 -containing 6-membered ring,

in Formula 1, ring CY 2 is a C 3 -C 60 carbocyclic group or a C 1 -C 60 heterocyclic group,

in Formula 1, X 31 to X 36 and X 41 to X 44 are each independently C or N,

in Formula 1, X 51 is *—N(R 5 )—*′, *—B(R 5 )—*′, *—P(R 5 )—*′, *—C(R 5a )(R 5b )—*′, *—Si(R 5a )(R 5b )—*′, *—Ge(R 5a )(R 5b )*′, *—S—*′, *—Se—*′, *—O—*′, *—C(═O)*′, *—S(═O)—*′*—S(═O) 2 —*′*—C(R 5 )═*′, *═C(R 5 )—*′, *—C(R 5a )═C(R 5b )—*′, *—C(═S)—*′, or *—C≡C*′, wherein * and *′ each indicate a binding site to a neighboring atom,

in Formula 1, L 1 is a single bond, a C 3 -C 60 carbocyclic group unsubstituted or substituted with at least one R 10a , or a C 1 -C 60 heterocyclic group unsubstituted or substituted with at least one R 10a ,

in Formula 1, b1 is an integer in a range from 1 to 5,

in Formula 1, R 1 to R 5 , R 5a , and R 5b are each independently a group represented by Formula 1-1, a group represented by Formula 1-2, hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C 1 -C 60 alkyl group unsubstituted or substituted with at least one R 10a , a C 2 -C 60 alkenyl group unsubstituted or substituted with at least one R 10a , a C 2 -C 60 alkynyl group unsubstituted or substituted with at least one R 10a , a C 1 -C 60 alkoxy group unsubstituted or substituted with at least one R 10a , a C 3 -C 60 carbocyclic group unsubstituted or substituted with at least one R 10a , a C 1 -C 60 heterocyclic group unsubstituted or substituted with at least one R 10a , a C 6 -C 60 aryloxy group unsubstituted or substituted with at least one R 10a , a C 6 -C 60 arylthio group unsubstituted or substituted with at least one R 10a , —C(Q 1 )(Q 2 )(Q 3 ), —Si(Q 1 )(Q 2 )(Q 3 ), —N(Q 1 )(Q 2 ), —B(Q 1 )(Q 2 ), —C(═O)(Q 1 ), —S(═O) 2 (Q 1 ), or —P(═O)(Q 1 )(Q 2 ),

in Formula 1, c1 is an integer in a range from 0 to 5, a1 and a4 are each independently an integer in a range from 0 to 4, a2 is an integer in a range from 0 to 10, a3 is an integer in a range from 0 to 6, the sum of a1 to a4 is 1 or more, at least one of a group(s) represented by *-(L 1 ) b1 -(R 1 ) c1 in the number of a1, at least one of R 2 (s) in the number of a2, at least one of R 3 (s) in the number of a3, at least one of R 4 (s) in the number of a4, or any combination thereof is each independently a group represented by Formula 1-1 or a group represented by Formula 1-2,

in Formulae 1-1 and 1-2, L 7 is a single bond, a C 3 -C 60 carbocyclic group unsubstituted or substituted with at least one R 10a , or a C 1 -C 60 heterocyclic group unsubstituted or substituted with at least one R 10a ,

in Formulae 1-1 and 1-2, b7 is an integer in a range from 1 to 5,

in Formulae 1-1 and 1-2, ring CY 7 is a C 3 -C 60 carbocyclic group or a C 1 -C 60 heterocyclic group,

in Formulae 1-1 and 1-2, n7 is an integer in a range from 1 to 5,

in Formula 1-1, ring CY 8 is a non-aromatic C 3 -C 60 carbocyclic group or a non-aromatic C 1 -C 60 heterocyclic group,

in Formulae 1-1 and 1-2, R 7 to R 9 are each the same as described in connection with R 1 , provided that, at least one of R 8 and R 9 is not hydrogen,

in Formulae 1-1 and 1-2, a7 and a8 are each independently an integer in a range from 0 to 20,

two or more selected from a group(s) represented by *-(L 1 ) b1 -(R 1 ) c1 in the number of a1 are optionally linked together to form a C 3 -C 60 carbocyclic group that is unsubstituted or substituted with at least one R 10a or a C 1 -C 60 heterocyclic group that is unsubstituted or substituted with at least one R 10a ,

two or more selected from R 2 (s) in the number of a2 are optionally linked together to form a C 3 -C 60 carbocyclic group that is unsubstituted or substituted with at least one R 10a or a C 1 -C 60 heterocyclic group that is unsubstituted or substituted with at least one R 10a ,

two or more selected from R 3 (s) in the number of a3 are optionally linked together to form a C 3 -C 60 carbocyclic group that is unsubstituted or substituted with at least one R 10a or a C 1 -C 60 heterocyclic group that is unsubstituted or substituted with at least one R 10a ,

two or more selected from R 4 (s) in the number of a4 are optionally linked together to form a C 3 -C 60 carbocyclic group that is unsubstituted or substituted with at least one R 10a or a C 1 -C 60 heterocyclic group that is unsubstituted or substituted with at least one R 10a , two or more selected from R 1 to R 5 , R 5a , and R 5b are optionally linked together to form a C 3 -C 60 carbocyclic group that is unsubstituted or substituted with at least one R 10a or a C 1 -C 60 heterocyclic group that is unsubstituted or substituted with at least one R 10a ,

R 10a is:

deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, or a nitro group;

a C 1 -C 60 alkyl group, a C 2 -C 60 alkenyl group, a C 2 -C 60 alkynyl group, or a C 1 -C 60 alkoxy group, each unsubstituted or substituted with deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C 3 -C 60 carbocyclic group, a C 1 -C 60 heterocyclic group, a C 6 -C 60 aryloxy group, a C 6 -C 60 arylthio group, —Si(Q 11 )(Q 12 )(Q 13 ), —N(Q 11 )(Q 12 ), —B(Q 11 )(Q 12 ), —C(═O)(Q 11 ), —S(═O) 2 (Q 11 ), —P(═O)(Q 11 )(Q 12 ), or any combination thereof;

a C 3 -C 60 carbocyclic group, a C 1 -C 60 heterocyclic group, a C 6 -C 60 aryloxy group, or a C 6 -C 60 arylthio group, each unsubstituted or substituted with deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C 1 -C 60 alkyl group, a C 2 -C 60 alkenyl group, a C 2 -C 60 alkynyl group, a C 1 -C 60 alkoxy group, a C 3 -C 60 carbocyclic group, a C 1 -C 60 heterocyclic group, a C 6 -C 60 aryloxy group, a C 6 -C 60 arylthio group, —Si(Q 21 )(Q 22 )(Q 23 ), —N(Q 21 )(Q 22 ), —B(Q 21 )(Q 22 ), —C(═O)(Q 21 ), —S(═O) 2 (Q 21 ), —P(═O)(Q 21 )(Q 22 ), or any combination thereof; or

—Si(Q 31 )(Q 32 )(Q 33 ), —N(Q 31 )(Q 32 ), —B(Q 31 )(Q 32 ), —C(═O)(Q 31 ), —S(═O) 2 (Q 31 ), or —P(═O)(Q 31 )(Q 32 ), and

Q 1 to Q 3 , Q 11 to Q 13 , Q 21 to Q 23 , and Q 31 to Q 33 are each independently: hydrogen; deuterium; —F; —Cl; —Br; —I; a hydroxyl group; a cyano group; a nitro group; a C 1 -C 60 alkyl group unsubstituted or substituted with deuterium, —F, a cyano group, a C 1 -C 60 alkyl group, a C 1 -C 60 alkoxy group, a phenyl group, a biphenyl group, a pyridinyl group, a pyrimidinyl group, a pyridazinyl group, a pyrazinyl group, a triazinyl group, or any combination thereof; a C 2 -C 60 alkenyl group; a C 2 -C 60 alkynyl group; a C 1 -C 60 alkoxy group; or a C 3 -C 60 carbocyclic group or a C 1 -C 60 heterocyclic group, each unsubstituted or substituted with deuterium, —F, a cyano group, a C 1 -C 60 alkyl group, a C 1 -C 60 alkoxy group, a phenyl group, a biphenyl group, a pyridinyl group, a pyrimidinyl group, a pyridazinyl group, a pyrazinyl group, a triazinyl group, or any combination thereof.

2. The light-emitting device of claim 1 , wherein:

in ring CY 1 of Formula 1, the X 1 -containing 5-membered ring is a pyrrole group, a pyrazole group, an imidazole group, a triazole group, an oxazole group, an isoxazole group, a thiazole group, an isothiazole group, an oxadiazole group, or a thiadiazole group, and

in ring CY 1 of Formula 1, the 6-membered ring condensed with the X 1 -containing 5-membered ring, or the X 1 -containing 6-membered ring, is a benzene group, a pyridine group, or a pyrimidine group.

3. The light-emitting device of claim 1 , wherein a4 in Formula 1 is an integer in a range from 1 to 4, and at least one of R 4 (s) in the number of a4 is each independently a group represented by Formula 1-1 or a group represented by Formula 1-2.

4. The light-emitting device of claim 1 , wherein:

in Formulae 1-1 and 1-2, ring CY 7 is i) a first ring, ii) a second ring, iii) a condensed cyclic group in which two or more first rings are condensed with each other, iv) a condensed cyclic group in which two or more second rings are condensed with each other, or v) a condensed cyclic group in which at least one first ring is condensed with at least one second ring,

the first ring is a cyclopentane group, a cyclohexane group, a cycloheptane group, a cyclooctane group, a cyclopentene group, a cyclohexene group, a cycloheptene group, a cyclooctene group, an adamantane group, a norbornene group, a norbornane group, a bicyclo[1.1.1] pentane group, a bicyclo[2.1.1] hexane group, a bicyclo[2.2.2] octane group, or a benzene group, and

the second ring is a pyrrole group, a furan group, a thiophene group, a silole group, a pyrazole group, an imidazole group, a triazole group, an oxazole group, an isoxazole group, a thiazole group, an isothiazole group, an oxadiazole group, a thiadiazole group, a pyridine group, a pyrimidine group, a pyridazine group, a pyrazine group, a triazine group, a 1,2-azaborinine group, a 1,3-azaborinine group, a 1,4-azaborinine group, a 1,2-dihydro-1,2-azaborinine group, a 1,4-oxaborinine group, a 1,4-thiaborinine group, or a 1,4-dihydroborinine group.

5. The light-emitting device of claim 1 , wherein ring CY 8 in Formula 1-1 is a cyclopentane group, a cyclohexane group, a cycloheptane group, a cyclooctane group, a cyclopentene group, a cyclohexene group, a cycloheptene group, a cyclooctene group, an adamantane group, a norbornene group, a norbornane group, a bicyclo[1.1.1] pentane group, a bicyclo[2.1.1] hexane group, or a bicyclo[2.2.2] octane group.

6. The light-emitting device of claim 1 , wherein ring CY 8 in Formula 1-1 is a group represented by one of Formulae CY8-1 to CY8-8:

wherein, in Formulae CY8-1 to CY8-8, * indicates a binding site to a neighboring atom in Formula 1, and * indicates a binding site to a neighboring atom in Formula 1-1.

7. The light-emitting device of claim 1 , wherein:

the first electrode is an anode,

the second electrode is a cathode,

the interlayer further comprises a hole transport region between the first electrode and the emission layer and an electron transport region between the emission layer and the second electrode,

the hole transport region includes a hole injection layer, a hole transport layer, an emission auxiliary layer, an electron blocking layer, or any combination thereof, and

the electron transport region further includes a buffer layer, a hole blocking layer, an electron control layer, an electron transport layer, an electron injection layer, or any combination thereof.

8. The light-emitting device of claim 1 , further comprising a capping layer outside the second electrode, the capping layer comprising a material having a refractive index of equal to or greater than 1.6.

9. The light-emitting device of claim 1 , wherein the emission layer emits blue light having a maximum emission wavelength in a range of 410 nm to 500 nm.

10. The light-emitting device of claim 1 , wherein:

the emission layer comprises a host and a dopant, and

the dopant comprises the organometallic compound.

11. A light-emitting device comprising:

a first electrode;

a second electrode facing the first electrode;

an interlayer between the first electrode and the second electrode and comprising an emission layer,

wherein the emission layer comprises an organometallic compound represented by Formula 1:

wherein, in Formula 1, M is platinum (Pt), palladium (Pd), gold (Au), nickel (Ni), silver (Ag), or copper (Cu),

in Formula 1, X 1 to X 4 are each independently C or N,

in Formula 1, i) a bond between X 1 and M is a coordinate bond, and ii) one bond selected from a bond between X 2 and M, a bond between X 3 and M, and a bond between X 4 and M is a coordinate bond, and the remaining two bonds are covalent bonds,

in Formula 1, ring CY 1 is i) an X 1 -containing 5-membered ring, ii) an X 1 -containing 5-membered ring condensed with at least one 6-membered ring, or iii) an X 1 -containing 6-membered ring,

in Formula 1, ring CY 2 is a C 3 -C 60 carbocyclic group or a C 1 -C 60 heterocyclic group,

in Formula 1, X 31 to X 36 and X 41 to X 44 are each independently C or N,

in Formula 1, X 51 is *—N(R 5 )—*′, *—B(R 5 )—*′, *—P(R 5 )—*′, *—C(R 5a )(R 5b )—*′, *—Si(R 5a )(R 5b )—*′, *—Ge(R 5a )(R 5b )*′, *—S—*′, *—Se—*′, *—O—*′, *—C(═O)*′, *—S(═O)—*′*—S(═O) 2 —*′, *—C(R 5 )═*′, *═C(R 5 )—*′, *—C(R 5a )═C(R 5b )—*′, *—C(═S)—*′, or *—C≡C*′, wherein * and *′ each indicate a binding site to a neighboring atom,

in Formula 1, L 1 is a single bond, a C 3 -C 60 carbocyclic group unsubstituted or substituted with at least one R 10a , or a C 1 -C 60 heterocyclic group unsubstituted or substituted with at least one R 10a ,

in Formula 1, b1 is an integer in a range from 1 to 5,

in Formula 1, R 1 to R 5 , R 5a , and R 5b are each independently a group represented by Formula 1-1, a group represented by Formula 1-2, hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C 1 -C 60 alkyl group unsubstituted or substituted with at least one R 10a , a C 2 -C 60 alkenyl group unsubstituted or substituted with at least one R 10a , a C 2 -C 60 alkynyl group unsubstituted or substituted with at least one R 10a , a C 1 -C 60 alkoxy group unsubstituted or substituted with at least one R 10a , a C 3 -C 60 carbocyclic group unsubstituted or substituted with at least one R 10a , a C 1 -C 60 heterocyclic group unsubstituted or substituted with at least one R 10a , a C 6 -C 60 aryloxy group unsubstituted or substituted with at least one R 10a , a C 6 -C 60 arylthio group unsubstituted or substituted with at least one R 10a , —C(Q 1 )(Q 2 )(Q 3 ), —Si(Q 1 )(Q 2 )(Q 3 ), —N(Q 1 )(Q 2 ), —B(Q 1 )(Q 2 ), —C(═O)(Q 1 ), —S(═O) 2 (Q 1 ), or —P(═O)(Q 1 )(Q 2 ),

in Formula 1, c1 is an integer in a range from 0 to 5, a1 and a4 are each independently an integer in a range from 0 to 4, a2 is an integer in a range from 0 to 10, a3 is an integer in a range from 0 to 6, the sum of a1 to a4 is 1 or more, at least one of a group(s) represented by *-(L 1 ) b1 -(R 1 ) c1 in the number of a1, at least one of R 2 (s) in the number of a2, at least one of R 3 (s) in the number of a3, at least one of R 4 (s) in the number of a4, or any combination thereof is each independently a group represented by Formula 1-1 or a group represented by Formula 1-2,

in Formulae 1-1 and 1-2, L 7 is a single bond, a C 3 -C 60 carbocyclic group unsubstituted or substituted with at least one R 10a , or a C 1 -C 60 heterocyclic group unsubstituted or substituted with at least one R 10a ,

in Formulae 1-1 and 1-2, b7 is an integer in a range from 1 to 5,

in Formulae 1-1 and 1-2, ring CY 7 is a C 3 -C 60 carbocyclic group or a C 1 -C 60 heterocyclic group,

in Formulae 1-1 and 1-2, n7 is an integer in a range from 1 to 5,

in Formula 1-1, ring CY 8 is a non-aromatic C 3 -C 60 carbocyclic group or a non-aromatic C 1 -C 60 heterocyclic group,

in Formulae 1-1 and 1-2, R 7 to R 9 are each the same as described in connection with R 1 ,

in Formulae 1-1 and 1-2, a7 and a8 are each independently an integer in a range from 0 to 20,

two or more selected from a group(s) represented by *-(L 1 ) b1 -(R 1 ) c1 in the number of a1 are optionally linked together to form a C 3 -C 60 carbocyclic group that is unsubstituted or substituted with at least one R 10a or a C 1 -C 60 heterocyclic group that is unsubstituted or substituted with at least one R 10a ,

two or more selected from R 2 (s) in the number of a2 are optionally linked together to form a C 3 -C 60 carbocyclic group that is unsubstituted or substituted with at least one R 10a or a C 1 -C 60 heterocyclic group that is unsubstituted or substituted with at least one R 10a ,

two or more selected from R 3 (s) in the number of a3 are optionally linked together to form a C 3 -C 60 carbocyclic group that is unsubstituted or substituted with at least one R 10a or a C 1 -C 60 heterocyclic group that is unsubstituted or substituted with at least one R 10a ,

two or more selected from R 4 (s) in the number of a4 are optionally linked together to form a C 3 -C 60 carbocyclic group that is unsubstituted or substituted with at least one R 10a or a C 1 -C 60 heterocyclic group that is unsubstituted or substituted with at least one R 10a ,

two or more selected from R 1 to R 5 , R 5a , and R 5b are optionally linked together to form a C 3 -C 60 carbocyclic group that is unsubstituted or substituted with at least one R 10a or a C 1 -C 60 heterocyclic group that is unsubstituted or substituted with at least one R 10a ,

R 10a is:

deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, or a nitro group;

a C 1 -C 60 alkyl group, a C 2 -C 60 alkenyl group, a C 2 -C 60 alkynyl group, or a C 1 -C 60 alkoxy group, each unsubstituted or substituted with deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C 3 -C 60 carbocyclic group, a C 1 -C 60 heterocyclic group, a C 6 -C 60 aryloxy group, a C 6 -C 60 arylthio group, —Si(Q 11 )(Q 12 )(Q 13 ), —N(Q 11 )(Q 12 ), —B(Q 11 )(Q 12 ), —C(═O)(Q 11 ), —S(═O) 2 (Q 11 ), —P(═O)(Q 11 )(Q 12 ), or any combination thereof;

a C 3 -C 60 carbocyclic group, a C 1 -C 60 heterocyclic group, a C 6 -C 60 aryloxy group, or a C 6 -C 60 arylthio group, each unsubstituted or substituted with deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C 1 -C 60 alkyl group, a C 2 -C 60 alkenyl group, a C 2 -C 60 alkynyl group, a C 1 -C 60 alkoxy group, a C 3 -C 60 carbocyclic group, a C 1 -C 60 heterocyclic group, a C 6 -C 60 aryloxy group, a C 6 -C 60 arylthio group, —Si(Q 21 )(Q 22 )(Q 23 ), —N(Q 21 )(Q 22 ), —B(Q 21 )(Q 22 ), —C(═O)(Q 21 ), —S(═O) 2 (Q 21 ), —P(═O)(Q 21 )(Q 22 ), or any combination thereof; or

—Si(Q 31 )(Q 32 )(Q 33 ), —N(Q 31 )(Q 32 ), —B(Q 31 )(Q 32 ), —C(═O)(Q 31 ), —S(═O) 2 (Q 31 ), or —P(═O)(Q 31 )(Q 32 ), and

Q 1 to Q 3 , Q 11 to Q 13 , Q 21 to Q 23 , and Q 31 to Q 33 are each independently: hydrogen; deuterium; —F; —Cl; —Br; —I; a hydroxyl group; a cyano group; a nitro group; a C 1 -C 60 alkyl group unsubstituted or substituted with deuterium, —F, a cyano group, a C 1 -C 60 alkyl group, a C 1 -C 60 alkoxy group, a phenyl group, a biphenyl group, a pyridinyl group, a pyrimidinyl group, a pyridazinyl group, a pyrazinyl group, a triazinyl group, or any combination thereof; a C 2 -C 60 alkenyl group; a C 2 -C 60 alkynyl group; a C 1 -C 60 alkoxy group; or a C 3 -C 60 carbocyclic group or a C 1 -C 60 heterocyclic group, each unsubstituted or substituted with deuterium, —F, a cyano group, a C 1 -C 60 alkyl group, a C 1 -C 60 alkoxy group, a phenyl group, a biphenyl group, a pyridinyl group, a pyrimidinyl group, a pyridazinyl group, a pyrazinyl group, a triazinyl group, or any combination thereof,

wherein:

the first electrode is an anode,

the second electrode is a cathode,

the interlayer further comprises a hole transport region between the first electrode and the emission layer and an electron transport region between the emission layer and the second electrode,

the hole transport region includes a hole injection layer, a hole transport layer, an emission auxiliary layer, an electron blocking layer, or any combination thereof, and the electron transport region further includes a buffer layer, a hole blocking layer,

an electron control layer, an electron transport layer, an electron injection layer, or any combination thereof,

wherein:

the electron transport region comprises the hole blocking layer, and

the hole blocking layer comprises a phosphine oxide-containing compound, a silicon-containing compound, or any combination thereof.

12. An electronic apparatus comprising the organic light-emitting device of claim 1 .

13. The electronic apparatus of claim 12 , wherein:

the electronic apparatus further comprises a thin-film transistor,

the thin-film transistor comprises a source electrode and a drain electrode, and

the first electrode of the light-emitting device is electrically coupled with at least one selected from the source electrode and the drain electrode of the thin-film transistor.

14. The electronic apparatus of claim 12 , wherein the electronic apparatus further comprises a color filter, a color conversion layer, a touch screen layer, a polarization layer, or any combination thereof.

15. An organometallic compound represented by Formula 1:

wherein, M in Formula 1 is platinum (Pt), palladium (Pd), gold (Au), nickel (Ni), silver (Ag), or copper (Cu),

X 1 to X 4 in Formula 1 are each independently C or N,

in Formula 1, i) a bond between X 1 and M is a coordinate bond, and ii) one bond selected from a bond between X 2 and M, a bond between X 3 and M, and a bond between X 4 and M is a coordinate bond, and the remaining two bonds are covalent bonds,

ring CY 1 in Formula 1 is i) an X 1 -containing 5-membered ring, ii) an X 1 -containing 5-membered ring condensed with at least one 6-membered ring, or iii) an X 1 -containing 6-membered ring,

ring CY 2 in Formula 1 is a C 3 -C 60 carbocyclic group or a C 1 -C 60 heterocyclic group,

X 31 to X 36 and X 41 to X 44 in Formula 1 are each independently C or N,

X 51 in Formula 1 is *—N(R 5 )—*′, *—B(R 5 )—*′, *—P(R 5 )—*′, *—C(R 5a )(R 5b )—*′, *—Si(R 5a )(R 5b )—*′, *—Ge(R 5a )(R 5b )*′, *—S—*′, *—Se—*′, *—O—*′, *—C(═O)*′, *—S(═O)—*′*—S(═O) 2 —*′*—C(R 5 )═*′, *═C(R 5 )—*′, *—C(R 5a )═C(R 5b )—*′, *—C(═S)—*′, or *—C≡C*′, wherein * and *′ each indicate a binding site to a neighboring atom,

L 1 in Formula 1 is a single bond, a C 3 -C 60 carbocyclic group unsubstituted or substituted with at least one R 10a , or a C 1 -C 60 heterocyclic group unsubstituted or substituted with at least one R 10a ,

b1 in Formula 1 is an integer in a range from 1 to 5,

R 1 to R 5 , R 5a , and R 5b in Formula 1 are each independently a group represented by Formula 1-1, a group represented by Formula 1-2, hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C 1 -C 60 alkyl group unsubstituted or substituted with at least one R 10a , a C 2 -C 60 alkenyl group unsubstituted or substituted with at least one R 10a , a C 2 -C 60 alkynyl group unsubstituted or substituted with at least one R 10a , a C 1 -C 60 alkoxy group unsubstituted or substituted with at least one R 10a , a C 3 -C 60 carbocyclic group unsubstituted or substituted with at least one R 10a , a C 1 -C 60 heterocyclic group unsubstituted or substituted with at least one R 10a , a C 6 -C 60 aryloxy group unsubstituted or substituted with at least one R 10a , a C 6 -C 60 arylthio group unsubstituted or substituted with at least one R 10a , —C(Q 1 )(Q 2 )(Q 3 ), —Si(Q 1 )(Q 2 )(Q 3 ), —N(Q 1 )(Q 2 ), —B(Q 1 )(Q 2 ), —C(═O)(Q 1 ), —S(═O) 2 (Q 1 ), or —P(═O)(Q 1 )(Q 2 ),

in Formula 1, c1 is an integer in a range from 0 to 5, a1 and a4 are each independently an integer in a range from 0 to 4, a2 is an integer in a range from 0 to 10, a3 is an integer in a range from 0 to 6, the sum of a1 to a4 is 1 or more, at least one of a group(s) represented by *-(L 1 ) b1 -(R 1 ) c1 in the number of a1, at least one of R 2 (s) in the number of a2, at least one of R 3 (s) in the number of a3, at least one of R 4 (s) in the number of a4, or any combination thereof is each independently a group represented by Formula 1-1 or a group represented by Formula 1-2,

in Formulae 1-1 and 1-2, L 7 is a single bond, a C 3 -C 60 carbocyclic group unsubstituted or substituted with at least one R 10a , or a C 1 -C 60 heterocyclic group unsubstituted or substituted with at least one R 10a ,

in Formulae 1-1 and 1-2, b7 is an integer in a range from 1 to 5,

in Formulae 1-1 and 1-2, ring CY 7 is a C 3 -C 60 carbocyclic group or a C 1 -C 60 heterocyclic group,

in Formulae 1-1 and 1-2, n7 is an integer in a range from 1 to 5,

in Formula 1-1, ring CY 8 is a non-aromatic C 3 -C 60 carbocyclic group or a non-aromatic C 1 -C 60 heterocyclic group,

in Formulae 1-1 and 1-2, R 7 to R 9 are each the same as described in connection with R 1 , provided that, at least one of R 8 and R 9 is not hydrogen,

in Formulae 1-1 and 1-2, a7 and a8 are each independently an integer in a range from 0 to 20,

two or more selected from a group(s) represented by *-(L 1 ) b1 -(R 1 ) c1 in the number of a1 are optionally linked together to form a C 3 -C 60 carbocyclic group that is unsubstituted or substituted with at least one R 10a or a C 1 -C 60 heterocyclic group that is unsubstituted or substituted with at least one R 10a ,

two or more selected from R 2 (s) in the number of a2 are optionally linked together to form a C 3 -C 60 carbocyclic group that is unsubstituted or substituted with at least one R 10a or a C 1 -C 60 heterocyclic group that is unsubstituted or substituted with at least one R 10a ,

two or more selected from R 3 (s) in the number of a3 are optionally linked together to form a C 3 -C 60 carbocyclic group that is unsubstituted or substituted with at least one R 10a or a C 1 -C 60 heterocyclic group that is unsubstituted or substituted with at least one R 10a ,

two or more selected from R 4 (s) in the number of a4 are optionally linked together to form a C 3 -C 60 carbocyclic group that is unsubstituted or substituted with at least one R 10a or a C 1 -C 60 heterocyclic group that is unsubstituted or substituted with at least one R 10a ,

two or more selected from R 1 to R 5 , R 5a , and R 5b are optionally linked together to form a C 3 -C 60 carbocyclic group that is unsubstituted or substituted with at least one R 10a or a C 1 -C 60 heterocyclic group that is unsubstituted or substituted with at least one R 10a ,

R 10a is:

deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, or a nitro group;

a C 1 -C 60 alkyl group, a C 2 -C 60 alkenyl group, a C 2 -C 60 alkynyl group, or a C 1 -C 60 alkoxy group, each unsubstituted or substituted with deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C 3 -C 60 carbocyclic group, a C 1 -C 60 heterocyclic group, a C 6 -C 60 aryloxy group, a C 6 -C 60 arylthio group, —Si(Q 11 )(Q 12 )(Q 13 ), —N(Q 11 )(Q 12 ), —B(Q 11 )(Q 12 ), —C(═O)(Q 11 ), —S(═O) 2 (Q 11 ), —P(═O)(Q 11 )(Q 12 ), or any combination thereof;

a C 3 -C 60 carbocyclic group, a C 1 -C 60 heterocyclic group, a C 6 -C 60 aryloxy group, or a C 6 -C 60 arylthio group, each unsubstituted or substituted with deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C 1 -C 60 alkyl group, a C 2 -C 60 alkenyl group, a C 2 -C 60 alkynyl group, a C 1 -C 60 alkoxy group, a C 3 -C 60 carbocyclic group, a C 1 -C 60 heterocyclic group, a C 6 -C 60 aryloxy group, a C 6 -C 60 arylthio group, —Si(Q 21 )(Q 22 )(Q 23 ), —N(Q 21 )(Q 22 ), —B(Q 21 )(Q 22 ), —C(═O)(Q 21 ), —S(═O) 2 (Q 21 ), —P(═O)(Q 21 )(Q 22 ), or any combination thereof; or

—Si(Q 31 )(Q 32 )(Q 33 ), —N(Q 31 )(Q 32 ), —B(Q 31 )(Q 32 ), —C(═O)(Q 31 ), —S(═O) 2 (Q 31 ), or —P(═O)(Q 31 )(Q 32 ), and

Q 1 to Q 3 , Q 11 to Q 13 , Q 21 to Q 23 , and Q 31 to Q 33 are each independently: hydrogen; deuterium; —F; —Cl; —Br; —I; a hydroxyl group; a cyano group; a nitro group; a C 1 -C 60 alkyl group unsubstituted or substituted with deuterium, —F, a cyano group, a C 1 -C 60 alkyl group, a C 1 -C 60 alkoxy group, a phenyl group, a biphenyl group, a pyridinyl group, a pyrimidinyl group, a pyridazinyl group, a pyrazinyl group, a triazinyl group, or any combination thereof; a C 2 -C 60 alkenyl group; a C 2 -C 60 alkynyl group; a C 1 -C 60 alkoxy group; or a C 3 -C 60 carbocyclic group or a C 1 -C 60 heterocyclic group, each unsubstituted or substituted with deuterium, —F, a cyano group, a C 1 -C 60 alkyl group, a C 1 -C 60 alkoxy group, a phenyl group, a biphenyl group, a pyridinyl group, a pyrimidinyl group, a pyridazinyl group, a pyrazinyl group, a triazinyl group, or any combination thereof.

16. The organometallic compound of claim 15 , wherein, in ring CY 1 of Formula 1, the X 1 -containing 5-membered ring is a pyrrole group, a pyrazole group, an imidazole group, a triazole group, an oxazole group, an isoxazole group, a thiazole group, an isothiazole group, an oxadiazole group, or a thiadiazole group, and

in ring CY 1 of Formula 1, the 6-membered ring condensed with the X 1 -containing 5-membered ring, or the X 1 -containing 6-membered ring, is a benzene group, a pyridine group, or a pyrimidine group.

17. The organometallic compound of claim 15 , wherein a4 in Formula 1 is an integer in a range from 1 to 4, and at least one of R 4 (s) in the number of a4 is each independently a group represented by Formula 1-1 or a group represented by Formula 1-2.

18. The organometallic compound of claim 15 , wherein:

in Formulae 1-1 and 1-2, ring CY 7 is i) a first ring, ii) a second ring, iii) a condensed cyclic group in which two or more first rings are condensed with each other, iv) a condensed cyclic group in which two or more second rings are condensed with each other, or v) a condensed cyclic group in which at least one first ring is condensed with at least one second ring,

the first ring is a cyclopentane group, a cyclohexane group, a cycloheptane group, a cyclooctane group, a cyclopentene group, a cyclohexene group, a cycloheptene group, a cyclooctene group, an adamantane group, a norbornene group, a norbornane group, a bicyclo[1.1.1] pentane group, a bicyclo[2.1.1] hexane group, a bicyclo[2.2.2] octane group, or a benzene group, and

the second ring is a pyrrole group, a furan group, a thiophene group, a silole group, a pyrazole group, an imidazole group, a triazole group, an oxazole group, an isoxazole group, a thiazole group, an isothiazole group, an oxadiazole group, a thiadiazole group, a pyridine group, a pyrimidine group, a pyridazine group, a pyrazine group, a triazine group, a 1,2-azaborinine group, a 1,3-azaborinine group, a 1,4-azaborinine group, a 1,2-dihydro-1,2-azaborinine group, a 1,4-oxaborinine group, a 1,4-thiaborinine group, or a 1,4-dihydroborinine group.

19. The organometallic compound of claim 15 , wherein ring CY 8 in Formula 1-1 is a cyclopentane group, a cyclohexane group, a cycloheptane group, a cyclooctane group, a cyclopentene group, a cyclohexene group, a cycloheptene group, a cyclooctene group, an adamantane group, a norbornene group, a norbornane group, a bicyclo[1.1.1] pentane group, a bicyclo[2.1.1] hexane group, or a bicyclo[2.2.2] octane group.

20. The organometallic compound of claim 15 , wherein ring CY 8 in Formula 1-1 is a group represented by one of Formulae CY8-1 to CY8-8:

wherein, in Formulae CY8-1 to CY8-8, * indicates a binding site to a neighboring atom in Formula 1, and *′ indicates a binding site to a neighboring atom in Formula 1-1.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2021
From: HAN, JUNGHOON; KWON, SOONKI; KIM, YUNHI; KO, SOOBYUNG; LEE, JAESUNG; SUNG, MINJAE
To: SAMSUNG DISPLAY CO., LTD.; INDUSTRY-ACADEMIC COOPERATION FOUNDATION GYEONGSANG NATIONAL UNIVERSITY
Reel/Frame 056644/0390 →
Priority Claims (1)
KR 10-2020-0086449 · Jul 13, 2020 · national
Continuity (1)
Related Publication 20220013738A1 · Jan 13, 2022
References Cited (60)
US 7381479B2 · Lamansky et al. · 2008 [cited by applicant]
US 7393599B2 · Thompson et al. · 2008 [cited by applicant]
US 7585573B2 · Lee et al. · 2009 [cited by applicant]
US 7776458B2 · Ragini et al. · 2010 [cited by applicant]
US 8106199B2 · Jabbour et al. · 2012 [cited by applicant]
US 8389725B2 · Li et al. · 2013 [cited by applicant]
US 8669364B2 · Li et al. · 2014 [cited by applicant]
US 8680760B2 · Cheng et al. · 2014 [cited by applicant]
US 8816080B2 · Li et al. · 2014 [cited by applicant]
US 8846940B2 · Li et al. · 2014 [cited by applicant]
US 8946417B2 · Jian et al. · 2015 [cited by applicant]
US 9051344B2 · Lin et al. · 2015 [cited by applicant]
US 9076974B2 · Li et al. · 2015 [cited by applicant]
US 9203039B2 · Li et al. · 2015 [cited by applicant]
US 9221857B2 · Li et al. · 2015 [cited by applicant]
US 9224963B2 · Li et al. · 2015 [cited by applicant]
US 9238668B2 · Li et al. · 2016 [cited by applicant]
US 9312502B2 · Li et al. · 2016 [cited by applicant]
US 9324957B2 · Li et al. · 2016 [cited by applicant]
US 9331290B2 · Stoessel et al. · 2016 [cited by applicant]
US 9382273B2 · Li et al. · 2016 [cited by applicant]
US 9425415B2 · Li et al. · 2016 [cited by applicant]
US 9698359B2 · Li et al. · 2017 [cited by applicant]
US 9899614B2 · Li et al. · 2018 [cited by applicant]
US 10008678B2 · Tsai et al. · 2018 [cited by applicant]
US 10211414B2 · Li et al. · 2019 [cited by applicant]
US 10700295B2 · Bochmann et al. · 2020 [cited by applicant]
US 20050287394A1 · Yang et al. · 2005 [cited by applicant]
US 20080018221A1 · Egen et al. · 2008 [cited by applicant]
US 20140309428A1 · Egen et al. · 2014 [cited by applicant]
US 20160072082A1 · Brooks et al. · 2016 [cited by applicant]
US 20190036055A1 · Lin et al. · 2019 [cited by applicant]
US 20190074468A1 · Kwak et al. · 2019 [cited by applicant]
US 20190109287A1 · Wu et al. · 2019 [cited by applicant]
US 20190119312A1 · Chen et al. · 2019 [cited by applicant]
US 20190207128A1 · Brooks · 2019 [cited by examiner]
US 20190296254A1 · Ko · 2019 [cited by examiner]
US 20200199164A1 · Kim · 2020 [cited by examiner]
US 20200216481A1 · Chen · 2020 [cited by examiner]
US 20200392173A1 · Bae et al. · 2020 [cited by applicant]
US 20210171548A1 · Min · 2021 [cited by examiner]
US 20210359227A1 · Shin et al. · 2021 [cited by applicant]
US 20210367167A1 · Lee · 2021 [cited by examiner]
US 20220024958A1 · Ko · 2022 [cited by examiner]
US 20220041637A1 · Tsai · 2022 [cited by examiner]
US 20230200228A1 · Kim · 2023 [cited by examiner]
CN 104370974A · 2015 [cited by applicant]
CN 109111487A · 2019 [cited by applicant]
CN 109309168A · 2019 [cited by applicant]
CN 112079870A · 2020 [cited by applicant]
CN 113690395A · 2021 [cited by applicant]
JP 2007045742A · 2007 [cited by applicant]
KR 100730115B1 · 2007 [cited by applicant]
KR 1020130095259A · 2013 [cited by applicant]
KR 1020140144152A · 2014 [cited by applicant]
KR 101636100B1 · 2016 [cited by applicant]
KR 1020180055853A · 2018 [cited by applicant]
KR 1020190026618A · 2019 [cited by applicant]
KR 1020200076583A · 2020 [cited by applicant]
WO WO2012121936A2 · 2012 [cited by applicant]